Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure

Khoury, H. Jean ; Cortes, Jorge E. ; Kantarjian, Hagop M. ; Gambacorti-Passerini, Carlo ; Baccarani, Michele ; Kim, Dong-Wook ; Zaritskey, Andrey ; Countouriotis, Athena ; Besson, Nadine ; Leip, Eric ; Kelly, Virginia ; Brümmendorf, Tim H.

Blood, 2012-04, Vol.119 (15), p.3403-3412 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível